Kamke Trent G's Form 4 filing
Lemaitre Vascular Inc (LMAT) · filed Mar 13, 2026
- Accession no.
- 0001193125-26-106295
- Filed
- Mar 13, 2026
- Trade date
- Mar 11, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $284.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kamke Trent GCIK 0001365739 | Officer (Senior V. P., Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Common Stock | MOption exerciseAcquired | +2,625 | $35.48 | +$93,135 | 9,302 | Direct | |
| Mar 11, 2026 | Common Stock | SSaleDisposed | −2,625 | $108.50 | −$284,812.5 | 6,677 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Common Stock | MOption exerciseDisposed | −2,625 | $0.00 | $0 | 1,353 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.